Skip to main content

Advertisement

Fig. 5 | BMC Cancer

Fig. 5

From: Sequential therapeutic targeting of ovarian Cancer harboring dysfunctional BRCA1

Fig. 5

Cell cycle analysis. SKOV3 (a and b) and SNU-251(a and c) cells were treated with different combinations of olaparib and cisplatin for 48 h, cells were synchronized and cell cycle analysis were performed using flow cytometry. d Protein expression of cell cycle related proteins (cyclin A, cyclin B and cyclin D1) were examined by western blot. Results are presented as means ± SEM for triplicates of three independent experiments, *p value < 0.05

Back to article page